Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (381-390 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|May 19, 2023
SARS-CoV-2 infection results in upregulation of Plasminogen Activator Inhibitor-1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severityKevin H Toomer, Gloria F Gerber, Yifan Zhang, et al.
Ejhaem|May 19, 2023
VHrare study: Prevalence, clinical features and management of severe rare bleeding disorders in a large cohortOlga Benítez Hidalgo, Maria Fernanda Martinez Garcia, Irene Corrrales Insa, et al.
Ejhaem|August 25, 2020
Coronavirus disease 2019 induces multi-lineage, morphologic changes in peripheral blood cellsFlorian Lüke, Evelyn Orsó, Jana Kirsten, et al.
Ejhaem|August 25, 2020
High percentage of smudge cells in a patient with COVID19: Rediscovering their utilityJoaquín Jerez, Daniel M Ernst
Ejhaem|August 14, 2025
Trends, Predictors, and Outcomes of Critically Ill Patients With Sickle Cell Disease in the United StatesTochukwu Nzeako, Olayemi Adeniran, Saranjeet Kaur, et al.
Ejhaem|August 5, 2025
Decitabine-Driven Foetal Haemoglobin Induction in Townes Mice and Human ErythroblastsAriadna Carol Illa, Desmond Wai Loon Chin, Martha Clark, et al.
Ejhaem|July 30, 2025
The Intersection of Lynch Syndrome and Hematological Malignancies: A Rare Short ReportTomomi Oka, Takeshi Nakajima, Makoto Iwasaki, et al.
Ejhaem|November 10, 2025
Clinical Presentation, Treatment, and Outcomes of 28 Patients With Castleman Disease: A Retrospective Analysis of an Italian CohortCaterina Cristinelli, Michele Merli, Marco Lucioni, et al.
Ejhaem|October 27, 2025
Polatuzumab Vedotin Induced CD20 Upregulation Contributes to the Efficacy of Mosunetuzumab in Combination With Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma Preclinical ModelsNatsumi Kawasaki, Sei Shu, Mayu Tomita, et al.
Ejhaem|October 31, 2025
Long-Term Safety Profile of Ruxolitinib in Chronic Myeloproliferative Neoplasms: A Comprehensive Real-World AnalysisAlberto Blanco-Sánchez, Rosa Ayala, Gonzalo Carreño-Tarragona, et al.
Pageof 93

Showing results (381-390 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|May 19, 2023
SARS-CoV-2 infection results in upregulation of Plasminogen Activator Inhibitor-1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severityKevin H Toomer, Gloria F Gerber, Yifan Zhang, et al.
Ejhaem|May 19, 2023
VHrare study: Prevalence, clinical features and management of severe rare bleeding disorders in a large cohortOlga Benítez Hidalgo, Maria Fernanda Martinez Garcia, Irene Corrrales Insa, et al.
Ejhaem|August 25, 2020
Coronavirus disease 2019 induces multi-lineage, morphologic changes in peripheral blood cellsFlorian Lüke, Evelyn Orsó, Jana Kirsten, et al.
Ejhaem|August 25, 2020
High percentage of smudge cells in a patient with COVID19: Rediscovering their utilityJoaquín Jerez, Daniel M Ernst
Ejhaem|August 14, 2025
Trends, Predictors, and Outcomes of Critically Ill Patients With Sickle Cell Disease in the United StatesTochukwu Nzeako, Olayemi Adeniran, Saranjeet Kaur, et al.
Ejhaem|August 5, 2025
Decitabine-Driven Foetal Haemoglobin Induction in Townes Mice and Human ErythroblastsAriadna Carol Illa, Desmond Wai Loon Chin, Martha Clark, et al.
Ejhaem|July 30, 2025
The Intersection of Lynch Syndrome and Hematological Malignancies: A Rare Short ReportTomomi Oka, Takeshi Nakajima, Makoto Iwasaki, et al.
Ejhaem|November 10, 2025
Clinical Presentation, Treatment, and Outcomes of 28 Patients With Castleman Disease: A Retrospective Analysis of an Italian CohortCaterina Cristinelli, Michele Merli, Marco Lucioni, et al.
Ejhaem|October 27, 2025
Polatuzumab Vedotin Induced CD20 Upregulation Contributes to the Efficacy of Mosunetuzumab in Combination With Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma Preclinical ModelsNatsumi Kawasaki, Sei Shu, Mayu Tomita, et al.
Ejhaem|October 31, 2025
Long-Term Safety Profile of Ruxolitinib in Chronic Myeloproliferative Neoplasms: A Comprehensive Real-World AnalysisAlberto Blanco-Sánchez, Rosa Ayala, Gonzalo Carreño-Tarragona, et al.
Pageof 93